Advanced GenAI Course 2025 For Software Developers and Engineers Launched – Interview Kickstart’s Generative AI Program With Agentic AI

Advanced GenAI Course 2025 For Software Developers and Engineers Launched – Interview Kickstart's Generative AI Program With Agentic AI GlobeNewswire August 18, 2025 Santa Clara, Aug. 18, 2025 (GLOBE NEWSWIRE) — As the software development landscape transforms unprecedentedly, AI-generated code is becoming one of the most disruptive innovations in the engineering world. With generative AI […]

New York Arbitrator Marc Goldstein Selected to Silicon Valley Arbitration Tech List®

Arbitrator Marc J.Goldstein of MJG Arbitration announced today that on August 15, 2025, he received the honor of selection by the Silicon Valley Arbitration & Mediation Center (SVAMC) to be included in its Tech List®, recognizing the world's top arbitrators and mediators with deep expertise in resolving complex technology disputes.According to the SVAMC, “[t]he Tech

Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation – SLP

https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public. So What: If you purchased Simulations Plus securities you may be entitled

Alto Neuroscience, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; September 19, 2025 Deadline to file Lead Plaintiff Motion

(NYSE:ANRO), Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 18, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Alto Neuroscience, Inc. (“Alto Neuroscience” or the “Company”) (NYSE: ANRO) investors of a class action representing investors that bought securities between February 2, 2024 and

SLQT Class Action Alert: Robbins LLP Reminds Investors of The Lead Plaintiff Deadline in The SelectQuote, Inc. Securities Fraud Class Action

SAN DIEGO, CA / ACCESS Newswire / August 18, 2025 / Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired SelectQuote, Inc. (NYSE:SLQT) securities between September 9, 2020 and May 1, 2025. SelectQuote is an insurance broker which sells Medicare Advantage and other health insurance

Alto Neuroscience, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; September 19, 2025 Deadline to file Lead Plaintiff Motion

Alto Neuroscience, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; September 19, 2025 Deadline to file Lead Plaintiff Motion GlobeNewswire August 18, 2025 Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 18, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm

CHTR Stockholder Notice: Robbins LLP Reminds Investors of The Class Action Lawsuit Against Charter Communications, Inc.

SAN DIEGO, CA / ACCESS Newswire / August 18, 2025 / Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Charter Communications, Inc. (NASDAQ:CHTR) securities, purchased call options on Charter common stock, or sold put options on Charter common stock, between July 26,

Levi & Korsinsky Urges Unicycive Therapeutics, Inc. (UNCY) Shareholders to Act Before Lead Plaintiff Deadline October 14, 2025

NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Unicycive Therapeutics, Inc. (NASDAQ:UNCY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unicycive-therapeutics-inc-lawsuit-submission-form?prid=162164&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

UNCY Stockholder Notice: Robbins LLP Reminds Investors of The Class Action Lawsuit Against Unicycive Therapeutics, Inc.

SAN DIEGO, CA / ACCESS Newswire / August 18, 2025 / Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Unicycive Therapeutics, Inc. (NASDAQ:UNCY) securities between March 29, 2024 and June 27, 2025. Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies

Scroll to Top